Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity - Bhingarkar, Aboli; Wang, Yuyin; Hoshitsuki, Keito; Eichinger, Katherine Marie; Rathod, Sanjay; Zhu, Yin; Lyu, He; McNutt, Andrew T.; Moreland, Larry W.; McDermott, Lee; Koes, David R.; Fernandez, Christian A. (Frontiers in Pharmacology, 2025)